Today’s 13GD Alert: Why Gilead Capital Lp Reported Big Landauer Inc Position?

Today's 13GD Alert: Why Gilead Capital Lp Reported Big Landauer Inc Position?

The New Gilead Capital Lp Holding in Landauer Inc

Gilead Capital Lp filed with the SEC SC 13D/A form for Landauer Inc. The form can be accessed here: 000119380516004314. As reported in Gilead Capital Lp’s form, the filler as of late owns 5% or 480,215 shares of the Health Care–company.

Landauer Inc stake is a new one for the and it was filed because of activity on November 28, 2016. We feel this shows Gilead Capital Lp’s positive view for the stock.

Landauer Inc Institutional Sentiment

Latest Security and Exchange filings show 116 investors own Landauer Inc. The institutional ownership in Q3 2015 is high, at 88.25% of the outstanding shares. This is increased by 187673 the total institutional shares. 8472157 were the shares owned by these institutional investors. In total 12 funds opened new Landauer Inc stakes, 41 increased stakes. There were 7 that closed positions and 39 reduced them.

Killen Group Inc is an institutional investor bullish on Landauer Inc, owning 467824 shares as of Q3 2015 for 1.61% of its portfolio. Jeffrey Moskowitz Harvey Partners Llc owns 160000 shares or 3.67% of its portfolio. CT Lapides Asset Management Llc have 0.30% of their stock portfolio for 46800 shares. Further, Punch & Associates Investment Management Inc reported stake worth 0.50% of its US stock portfolio. The CA Bernzott Capital Advisors owns 485775 shares. Landauer Inc is 4.13% of the manager’s US portfolio.

Business Profile

Landauer, Inc. (Landauer) is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a domestic provider of outsourced medical physics services and a provider of radiology related medical products. It operates in three business segments: Radiation Measurement, Medical Physics and Medical Products. The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure. The Medical Physics segment provides therapeutic and imaging physics services to domestic hospitals and radiation therapy centers. The Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures. The Company’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings.

SEC Form 13D is filed within 10 days, by anyone who acquires beneficial ownership of 5%+ of any public firm. Activist investors and practices such as: company breakups, hostile takeovers, and change of control events, are permitted for this form filers. A filer must promptly update its 13D filing in case of acquisition or disposition of 1% or more of the securities that are the subject of the filing.

Insitutional Activity: The institutional sentiment increased to 1.64 in Q2 2016. Its up 0.51, from 1.13 in 2016Q1. The ratio is positive, as 8 funds sold all Landauer Inc shares owned while 37 reduced positions. 15 funds bought stakes while 36 increased positions. They now own 8.13 million shares or 2.71% less from 8.35 million shares in 2016Q1.

Moreover, Old Second Commercial Bank Of Aurora has 0.01% invested in Landauer Inc (NYSE:LDR) for 400 shares. American Interest Gp holds 0% or 7,117 shares in its portfolio. Wasatch Advsrs Inc owns 215,768 shares or 0.14% of their US portfolio. Ameriprise Incorporated reported 45,946 shares or 0% of all its holdings. Ls Advsrs Limited Liability, a Michigan-based fund reported 402 shares. Walleye Trading Lc reported 400 shares or 0% of all its holdings. The Pennsylvania-based Nationwide Fund Advsr has invested 0% in Landauer Inc (NYSE:LDR). Moreover, Bernzott Capital Advsrs has 3.7% invested in Landauer Inc (NYSE:LDR) for 460,390 shares. Blackrock Limited has 0% invested in the company for 16,937 shares. State Common Retirement Fund last reported 0% of its portfolio in the stock. The United Kingdom-based Legal & General Public Ltd Company has invested 0% in Landauer Inc (NYSE:LDR). Comerica National Bank reported 9,561 shares or 0% of all its holdings. State Of Tennessee Treasury Department has 7,681 shares for 0% of their US portfolio. Arizona State Retirement System holds 0% of its portfolio in Landauer Inc (NYSE:LDR) for 4,961 shares. Nuveen Asset Mngmt Ltd Com holds 72,223 shares or 0.02% of its portfolio.

Analysts await Landauer Inc (NYSE:LDR) to report earnings on December, 12. They expect $0.29 earnings per share, down 27.50% or $0.11 from last year’s $0.4 per share. LDR’s profit will be $2.83M for 45.43 P/E if the $0.29 EPS becomes a reality. After $0.49 actual earnings per share reported by Landauer Inc for the previous quarter, Wall Street now forecasts -40.82% negative EPS growth.

The stock closed at $52.7 during the last session. It is down 51.96% since April 25, 2016 and is uptrending. It has outperformed by 45.95% the S&P500.

Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The company has a market cap of $513.93 million. The Firm is a domestic well-known provider of outsourced medical physics services and a well-known provider of radiology related medical products. It has a 28.5 P/E ratio. It operates in three business divisions: Radiation Measurement, Medical Physics and Medical Products.

Landauer Inc (NYSE:LDR) Ratings Coverage

Out of 2 analysts covering Landauer (NYSE:LDR), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Landauer has been the topic of 2 analyst reports since August 16, 2016 according to StockzIntelligence Inc. As per Tuesday, August 16, the company rating was downgraded by Sidoti. The rating was downgraded by Hilliard Lyons to “Underperform” on Friday, July 1.

More notable recent Landauer Inc (NYSE:LDR) news were published by: Prnewswire.com which released: “Landauer, Inc. Appoints Teri Fontenot to Board of Directors” on September 28, 2016, also Thestreet.com with their article: “Landauer Inc Stock Downgraded (LDR)” published on August 06, 2014, Marketwatch.com published: “Landauer downgraded to underperform from neutral at Hilliard Lyons” on December 21, 2009. More interesting news about Landauer Inc (NYSE:LDR) were released by: Prnewswire.com and their article: “Landauer, Inc. Reports Fiscal 2015 Fourth Quarter And Full Year Results” published on December 14, 2015 as well as Prnewswire.com‘s news article titled: “Landauer, Inc. Announces Dr. Craig Yoder To Lead Its Technology Advisory Board” with publication date: February 11, 2015.

According to Zacks Investment Research, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries.”

LDR Company Profile

Landauer, Inc. (Landauer), incorporated on November 23, 1987, is a well-known provider of technical and analytical services to determine occupational and environmental radiation exposure. The Firm is a domestic well-known provider of outsourced medical physics services and a well-known provider of radiology related medical products. It operates in three business divisions: Radiation Measurement, Medical Physics and Medical Products. The Company’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company’s services are provided to approximately 1.8 million individuals around the globe. In addition to providing analytical services, the Company sells dosimetry detectors and reading equipment to clients that want to manage their own dosimetry programs, or into smaller international markets. The Firm offers its service for measuring the dosages of x-ray, gamma radiation and other penetrating ionizing radiations. The Company’s technology is marketed under the trade names Luxel+ and InLight.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Leave a Comment